Better Coronavirus Stock: Gilead Sciences vs. Inovio Pharmaceuticals
The world is eagerly awaiting some good news in the fight against the coronavirus and COVID-19, the disease that the virus causes. Several drugmakers are scrambling to become the first to provide that good news.
Gilead Sciences (NASDAQ: GILD) and Inovio Pharmaceuticals (NASDAQ: INO) rank as two of the leaders in battling COVID-19. Which of these coronavirus-focused stocks is the better pick right now? Here's how Gilead and Inovio stack up against each other.
Image source: Getty Images.
Source Fool.com
